4.65
Lipella Pharmaceuticals Inc Stock (LIPO) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
0.1459
|
- | - | - | 0.118 |
|
1.3635
|
- | - | - | 1.2025 |
Benefits Costs and Expenses |
1.3377
|
- | - | - | 1.1859 |
Costs And Expenses |
1.3377
|
- | - | - | 1.1859 |
Operating Income/Loss |
66.89%
-1.2176
|
-0.7296 | -1.3567 | -1.5752 | -1.0844 |
Nonoperating Income/Loss |
36.53%
0.0258
|
0.0407 | 0.0332 | 0.0365 | 0.0166 |
Income/Loss From Continuing Operations Before Tax |
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
Income/Loss From Continuing Operations After Tax |
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
|
73.01%
-1.1918
|
-0.6889 | -1.3236 | -1.5387 | -1.0678 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,750%
7.2924
|
0.2558 | 5.7537 | 5.7439 | 5.7439 |
Diluted Average Shares |
2,750%
7.2924
|
0.2558 | 5.7537 | 5.7439 | 5.7439 |
Basic Earnings Per Share |
77.78%
-0.16
|
-0.09 | -0.23 | -0.27 | -0.19 |
Diluted Earnings Per Share |
77.78%
-0.16
|
-0.09 | -0.23 | -0.27 | -0.19 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):